Top Markets
#1 Black Phoenix Black Phoenix +862.28%
#2 QuantixAI QuantixAI +102.94%
#3 MetaDAO MetaDAO +24.81%
#4 Ontology Gas Ontology Gas +22.64%
#5 Bedrock Bedrock +21.40%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +20.28%
#7 Siren Siren +20.01%
#8 Pons Pons +19.78%
#9 龙虾 (Lobster) 龙虾 (Lobster) +18.47%
#10 Stacks Stacks +16.85%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Pozycja w akcjach #2340
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Cena akcji
$43.60
Kapitalizacja rynkowa
$9.00B
Zmiana (1 dzień)
0.65%
Zmiana (1 rok)
192.84%
Kraj
US
Handel Immunovant, Inc. (IMVT)

Kategoria

Healthcare
EPS dla Immunovant, Inc. (IMVT)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Immunovant, Inc., obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Immunovant, Inc. od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH